Welcome to The Symptoms Of Multiple Sclerosis
Multiple Sclerosis Sign Symptom Article
This is a selection among article about Multiple Sclerosis Sign Symptom. For a permanent link to this article, or to bookmark it for further reading, click here.
With Reports Of Death, FDA Warns Multiple Sclerosis (MS) Patients Against Pharmaceutical Drug Tysabri
from: By: Tracy LaxdalGreg Jones & Associates, a North Carolina-based law firm, in association with www.lawyersandsettlements.com, launches a marketing campaign to increase awareness of the Multiple Sclerosis drug, Tysabri. Makers of Tysabri, Biogen Idec Inc. and Elan Pharmaceuticals Inc., have recently taken the drug off the market and sent out warnings to doctors.
In November 2004, Biogen Idec and Elan Corporation received approval from the FDA to market and distribute Tysabri (natalizumab). Only four months later, February 2005, the drug was quickly removed from the market after the FDA received several reports of severe illness and death in patients prescribed Tysabri and Avonex. In several cases, the patient or corpse was diagnosed with Progressive Multifocal Leukoencephalopathy (PML), a rare brain infection that directly affects the central nervous system. Symptoms of PML are similar to a stroke: headaches, memory loss, speech and vision difficulties, limb weakness, and partial paralysis; the disease leads to coma then to death.
To date, approximately 3,000 patients have been involved in clinical trials or prescribed Tysabri for multiple sclerosis, Crohn's disease and rheumatoid arthritis. Biogen Idec and Elan Pharmaceuticals hope to redistribute the drug after extensive evaluations of Tysabri and the possible link to PML.
Biogen merged with IDEC Pharmaceuticals in 2003, creating the billion-dollar company, Biogen Idec, which is based in Cambridge, Massachusetts. Biogen Idec also has another MS drug in the news: the bread-winning drug, Avonex, the most widely prescribed Multiple Sclerosis drug in the world with revenues of $1.4 billion in 2004 has recently been linked to increased risk of liver damage and liver failure.
Greg Jones & Associates is urging patients that have had adverse side effects with the prescription drugs Tysabri or Avonex, to have their case reviewed at www.lawyersandsettlements.com; each case will be evaluated by a lawyer at no charge.
For more details about this product recall and potential class action lawsuit, visit https://www.lawyersandsettlements.com/case/tysabri
About The Author About Online Legal Services Ltd (OLS) and www.lawyersandsettlements.com OLS is a privately held Internet marketing company that specializes in joint advertising campaigns for lawyers and law firms. Lawyersandsettlements.com offers a comprehensive website with up-to-date information on legal news, class action lawsuits, personal injury cases, settlement details, product recalls, and more. Consumers can complete free case evaluations and subscribe to free newsletters. Visit us at: http://www.lawyersandsettlements.com/ tracyl@lawyersandsettlements.com |
This article was posted on August 04, 2005
Multiple Sclerosis Sign Symptom News
Push for MS treatment bolstered - Victoria Times Colonist
 CBC.ca | Push for MS treatment bolstered Victoria Times Colonist News that Saskatchewan will fund clinical trials of a controversial treatment for multiple sclerosis while ... Brad goes to the Wall for MS miracle cure |
Health Notes - Surfing event caters to wheelchair users - StarNewsOnline.com
Health Notes - Surfing event caters to wheelchair users StarNewsOnline.com WILMINGTON | Julie Frederiksen, a nurse practitioner at Wilmington Health Associates, recently achieved the credential of Multiple Sclerosis Certified Nurse ... |
Branded? Generic? They're Both Doing Great! - Motley Fool
 Ha'aretz | Branded? Generic? They're Both Doing Great! Motley Fool That's not to say the 21% increase in sales of its multiple sclerosis drug Copaxone isn't impressive; there's tough competition out there from Biogen Idec's ... Look at TEVA and ESRX Why did Teva's Shares Fall so Much on Friday? |
TheWallStreetLeader.com: Small Cap Stock News for Wednesday: Green Oasis ... - Trading Markets (press release)
TheWallStreetLeader.com: Small Cap Stock News for Wednesday: Green Oasis ... Trading Markets (press release) ... a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), Human Immunodeficiency Virus (HIV), Multiple Sclerosis (MS) and ... |
StockSource.us: OTCBB Penny Stock News Makers - NPHC, LIVC, CNBI, COWI - Trading Markets (press release)
StockSource.us: OTCBB Penny Stock News Makers - NPHC, LIVC, CNBI, COWI Trading Markets (press release) ... a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), Human Immunodeficiency Virus (HIV), Multiple Sclerosis (MS) and ... |
Small business development & consulting firm.